OPTION: Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation

Sponsor
Örebro University, Sweden (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04700969
Collaborator
Linkoeping University (Other), Karolinska Institutet (Other)
20
17
2
41.5
1.2
0

Study Details

Study Description

Brief Summary

Urinary retention (UR) is a common problem in older people undergoing hip surgery. Untreated UR can lead to bladder distention and a permanent damage of the bladder, which can cause both physical and psychical suffering as well as increased costs for society. Even if national and international practice guidelines are in place for handling UR within the health care system, many fail to comply with them. Compliance to clinical practice guidelines are improved if different professions and managers collaborate as a team. In OPTION (Onset PrevenTIon of urinary retention in Orthopedic Nursing and rehabilitation) the investigators will coach multi-professional local facilitator teams in knowledge translation and implementation of UR practice as well as investigate the effects of such evidence-based practice in orthopedic nursing and rehabilitation.

Implementation of research-based knowledge in evidence-based practice within an organization is complex with several known interacting factors. In a health care system these factors can be the care context, knowledge (innovation) and how the organization facilitates such implementations. The implementation strategy of OPTION utilize established theories of facilitation of knowledge implementation considering evidence and context with focus on leadership. The intervention consists of seminars and systematic support for implementation of UR-guidelines OPTION combine studies of adherence to evidence based practice regarding UR for patients over 65 years old that has undergone hip surgery and the health economic aspects of it. OPTION also contribute with improvements and increased knowledge regarding strategies to implement evidence based health care that can be used in other areas than UR and hip surgeries.

Condition or Disease Intervention/Treatment Phase
  • Other: : A support program to facilitate implementation of evidence-based practice for postoperative urinary retention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation, OPTION - a Knowledge Implementation Study on a Facilitation Strategy for Multi-professional Clinical Champion Teams
Actual Study Start Date :
Dec 15, 2020
Anticipated Primary Completion Date :
May 30, 2023
Anticipated Study Completion Date :
May 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: A support program to facilitate implementation of EBP for postoperative urinary retention

12- month support program. Multi-professional facilitator-teams will be supported by a 12-month support program including seminars and monthly supervision (e-discussion forum and group teleconferences) to develop an awareness of, and skills in facilitating implementation of evidence/EBP in clinical everyday care.

Other: : A support program to facilitate implementation of evidence-based practice for postoperative urinary retention
A 12-month implementation support program for multi-professional internal facilitator teams

No Intervention: Control-No support program

No support program

Outcome Measures

Primary Outcome Measures

  1. Adherence to UR guidelines in the care of patients undergoing hip surgery. [Change from base line to 1 year after the intervention]

    Adherence to national urinary retention guidelines documented in the patients' medical record

Secondary Outcome Measures

  1. Number of hip surgery patients with UR [Change from base line to 1 year after the intervention]

    Number of hip surgery patients with UR documented in the patients' medical record

  2. Patient participation [Change from base line to 1 year after the intervention]

    The Patient Preferences for Patient Participation tool (The 4Ps)

  3. Costs related to UR [Change from base line to 1 year after the intervention]

    Costs for device and labour for bladder scanning and urinary catheterization

  4. The IFs', staff's, and managers' experience of UR care [Change from base line to 1 year after the intervention]

    Investigated with qualitative interviews

  5. The IFs', staff's, and managers' experience of the facilitation program [1 year after the intervention]

    Investigated with qualitative interviews

  6. The experience of people undergoing hip surgery, regarding UR, UR care. [Change from base line to 1 year after the intervention]

    Investigated with qualitative interviews

  7. The impact of a knowledge translation support program on the peoples' experience of the above [Change from base line to 1 year after the intervention]

    Investigated with qualitative interviews

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Orthopaedic units in Sweden performing hip surgery. -

Exclusion Criteria: Orthopaedic units in Sweden not performing hip surgery

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sjukhuset Arvika Arvika Sweden
2 Danderyds sjukhus Danderyd Sweden
3 Höglandssjukhuset Eksjö Eksjö Sweden
4 Enköpings lasarett Enköping Sweden
5 Mälarsjukhuset Eskilstuna Sweden
6 Gävle sjukhus Gävle Sweden
7 Karolinska University Hospital, Huddinge Huddinge Sweden
8 Hudiksvalls sjukhus Hudiksvall Sweden
9 Capio Ortopediska huset Johanneshov Sweden
10 Karlskoga Lasarett Karlskoga Sweden
11 Vrinnevisjukhuset Norrköping Sweden
12 Nyköpings lasarett Nyköping Sweden
13 Södersjukhuset Stockholm Sweden
14 Södertälje sjukhus Södertälje Sweden
15 Sjukhuset Torsby Torsby Sweden
16 Västmanlands sjukhus Västerås Sweden
17 Örebro University Hospital Örebro Sweden

Sponsors and Collaborators

  • Örebro University, Sweden
  • Linkoeping University
  • Karolinska Institutet

Investigators

  • Principal Investigator: Maria Hälleberg Nyman, PHD, Örebro University, Sweden

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Örebro University, Sweden
ClinicalTrials.gov Identifier:
NCT04700969
Other Study ID Numbers:
  • ORU 2020/03330
First Posted:
Jan 8, 2021
Last Update Posted:
Apr 20, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Örebro University, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2022